Vimarsana
Biggest News Aggregation in the World

Page 14 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

Novartis reports success in phase 3 trial of drug for rare kidney disease - Vimarsana News

Novartis reports success in phase 3 trial of drug for rare kidney disease

Novartis reports positive topline results from a Phase 3 trial of iptacopan, a drug to treat a rare kidney disease, C3 glomerulopathy.

Phathom's impending heartburn treatement given NDA by FDA - Vimarsana News

Phathom's impending heartburn treatement given NDA by FDA

Millions of US adults suffering from heartburn associated with non-erosive-gastroesophageal-reflux-disease (GERD) could benefit from an impending treatment by Phathom Pharmaceuticals.

Sickle cell cure: FDA advisory committee approves 2 gene editing treatment therapies, including CRISPR - Vimarsana News

Sickle cell cure: FDA advisory committee approves 2 gene editing treatment therapies, including CRISPR

New FDA-approved therapy treatments that use genetic modification called CRISPR may lead to a sickle cell disease cure.

Source: abc13.com
Casgevy gets FDA approval; made by Boston-based companies - Vimarsana News

Casgevy gets FDA approval; made by Boston-based companies

Casgevy, made by two Boston-based pharmaceutical companies, is the first gene therapy based on a technology sometimes called "genetic scissors."

Source: wcvb.com
Nephron faces lawsuit over pain med competitor says it sold without FDA approval - Vimarsana News

Nephron faces lawsuit over pain med competitor says it sold without FDA approval

A competing pharmaceutical company is suing SC’s Nephron over drugs it says the company sold without FDA approval, undercutting its own medication on the market.

Source: yahoo.com